Beliefs, preferences, and informational needs of patients with rheumatoid arthritis and concomitant cancer: a qualitative study
Abstract Background Treatment of rheumatoid arthritis (RA) with biologic drugs in patients with cancer could potentially result in poor cancer outcomes. This study aimed to identify the beliefs, preferences, and informational needs of patients with RA and cancer regarding the harms, benefits, and un...
| 出版年: | BMC Rheumatology |
|---|---|
| 主要な著者: | Juan I. Ruiz, Sheneze T. Madramootoo, Maria A. Lopez-Olivo, Namrata Singh, Maria E. Suarez-Almazor |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
BMC
2025-07-01
|
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s41927-025-00526-7 |
類似資料
Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials
著者:: Grace C. Wright, 等
出版事項: (2024-07-01)
著者:: Grace C. Wright, 等
出版事項: (2024-07-01)
Difficult-to-treat rheumatoid arthritis in the clinical practice of a rheumatological hospital. First look
著者:: A. V. Gordeev, 等
出版事項: (2022-05-01)
著者:: A. V. Gordeev, 等
出版事項: (2022-05-01)
Targeted Therapy for Rheumatoid Arthritis in the New Era
著者:: WANG Jun, 等
出版事項: (2025-01-01)
著者:: WANG Jun, 等
出版事項: (2025-01-01)
MODERN VIEWS ON PATHOGENETIC THERAPY OF RHEUMATOID ARTHRITIS
著者:: D. G. Rekalov, 等
出版事項: (2013-12-01)
著者:: D. G. Rekalov, 等
出版事項: (2013-12-01)
Serum IL-40 increases in patients with rheumatoid arthritis and correlates with some clinical characteristics and comorbidities
著者:: Wei Wang, 等
出版事項: (2024-11-01)
著者:: Wei Wang, 等
出版事項: (2024-11-01)
End-stage rheumatoid arthritis: specific features of patient management
著者:: Nadezhda Aleksandrovna Shostak, 等
出版事項: (2013-06-01)
著者:: Nadezhda Aleksandrovna Shostak, 等
出版事項: (2013-06-01)
Tofacitinib in the treatment of active rheumatoid arthritis – single-centre experience
著者:: Marta Madej, 等
出版事項: (2019-08-01)
著者:: Marta Madej, 等
出版事項: (2019-08-01)
A Canadian Retrospective Chart Review Evaluating Concomitant Methotrexate De-escalation Patterns in Patients with Rheumatoid Arthritis Treated with Biologic or Targeted Synthetic DMARDs
著者:: Louis Bessette, 等
出版事項: (2024-07-01)
著者:: Louis Bessette, 等
出版事項: (2024-07-01)
Early rheumatoid arthritis therapy: comparative characteristic of delagil, sulphasalazine and methotrexate
著者:: T S Salnikova, 等
出版事項: (2003-08-01)
著者:: T S Salnikova, 等
出版事項: (2003-08-01)
The tumor necrosis factor-α inhibitor golimumab in the treatment of rheumatoid arthritis
著者:: Natalia Vladimirovna Chichasova
出版事項: (2014-12-01)
著者:: Natalia Vladimirovna Chichasova
出版事項: (2014-12-01)
Cost-minimization analysis of subcutaneous abatacept in the treatment of rheumatoid arthritis in Spain
著者:: R. Ariza, 等
出版事項: (2014-07-01)
著者:: R. Ariza, 等
出版事項: (2014-07-01)
Rheumatoid arthritis: problems of treatment at the present stage
著者:: N. V. Chichasova
出版事項: (2018-12-01)
著者:: N. V. Chichasova
出版事項: (2018-12-01)
Conventional synthetic disease-modifying antirheumatic drug use by race/ethnicity and factors associated with initiating biologics in Malaysian patients with rheumatoid arthritis
著者:: Suad Mohammed, 等
出版事項: (2019-01-01)
著者:: Suad Mohammed, 等
出版事項: (2019-01-01)
Disease Activity in Disease Modifying Anti-Rheumatic Drug (DMARD) Naïve Rheumatoid Arthritis Patients in A Subset of Karachi Population
著者:: Dr. Mehreen Inam Illahi, 等
出版事項: (2024-05-01)
著者:: Dr. Mehreen Inam Illahi, 等
出版事項: (2024-05-01)
Geographic Analysis of the Safety and Efficacy of Filgotinib in Rheumatoid Arthritis
著者:: Bernard Combe, 等
出版事項: (2022-10-01)
著者:: Bernard Combe, 等
出版事項: (2022-10-01)
Rheumatoid arthritis – medication dosage in chronic kidney disease
著者:: Kinga Maria Tyczyńska, 等
出版事項: (2024-01-01)
著者:: Kinga Maria Tyczyńska, 等
出版事項: (2024-01-01)
Peculiarities of pharmacotherapy of patients with rheumatoid arthritis associated with interstitial lung disease
著者:: A. V. Gordeev, 等
出版事項: (2024-02-01)
著者:: A. V. Gordeev, 等
出版事項: (2024-02-01)
STRATEGY FOR DOSE REDUCTION AND DISCONTINUATION OF BIOLOGICAL AGENTS IN RHEUMATOID ARTHRITIS REMISSION
著者:: M. A. Kotovskaya, 等
出版事項: (2018-03-01)
著者:: M. A. Kotovskaya, 等
出版事項: (2018-03-01)
Evaluation of difficult-to-treat rheumatoid arthritis using EULAR definition: Prevalence and clinical determinants from a single-center cross-sectional study
著者:: Sevilay Batibay, 等
出版事項: (2025-04-01)
著者:: Sevilay Batibay, 等
出版事項: (2025-04-01)
Reduction in the need for glucocorticoids on the background of therapy with biologic disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis: evidence from real clinical practice
著者:: Alena S. Potapova, 等
出版事項: (2024-06-01)
著者:: Alena S. Potapova, 等
出版事項: (2024-06-01)
Comparison of treatment of severe rheumatoid arthritis patients with biological agents and JAK-STAT inhibitors. An extension study
著者:: Małgorzata Wisłowska
出版事項: (2024-11-01)
著者:: Małgorzata Wisłowska
出版事項: (2024-11-01)
The problem of laboratory monitoring in therapy with disease-modifying antirheumatic drugs and biological agents in patients with rheumatoid arthritis
著者:: Yu. V. Muravyev, 等
出版事項: (2018-09-01)
著者:: Yu. V. Muravyev, 等
出版事項: (2018-09-01)
Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study
著者:: Kosuke Ebina, 等
出版事項: (2019-04-01)
著者:: Kosuke Ebina, 等
出版事項: (2019-04-01)
Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis
著者:: Yinzhu Jin, 等
出版事項: (2017-07-01)
著者:: Yinzhu Jin, 等
出版事項: (2017-07-01)
Bioanalogues in the treatment of rheumatoid arthritis: current status of the problem
著者:: N. V. Chichasova, 等
出版事項: (2024-12-01)
著者:: N. V. Chichasova, 等
出版事項: (2024-12-01)
Gut dysbiosis is associated with difficult-to-treat rheumatoid arthritis
著者:: Patricia Ruiz-Limón, 等
出版事項: (2025-01-01)
著者:: Patricia Ruiz-Limón, 等
出版事項: (2025-01-01)
COVID-19 and post-covid syndrome in patients with rheumatoid arthritis
著者:: E. S. Aronova, 等
出版事項: (2023-08-01)
著者:: E. S. Aronova, 等
出版事項: (2023-08-01)
Patients With Rheumatoid Arthritis With an Inadequate Response to Disease‐Modifying Antirheumatic Drugs at a Higher Risk of Acute Coronary Syndrome
著者:: Chung‐Yuan Hsu, 等
出版事項: (2021-04-01)
著者:: Chung‐Yuan Hsu, 等
出版事項: (2021-04-01)
PERIOPERATIVE MANAGEMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS
著者:: V. N. Amirdzhanova, 等
出版事項: (2014-09-01)
著者:: V. N. Amirdzhanova, 等
出版事項: (2014-09-01)
Nitric Oxide Synthases in Rheumatoid Arthritis
著者:: Jia-Bao Huang, 等
出版事項: (2023-05-01)
著者:: Jia-Bao Huang, 等
出版事項: (2023-05-01)
Steroid-sparing effect of levilimab in rheumatoid arthritis in real practice
著者:: Larisa V. Ivanova, 等
出版事項: (2025-01-01)
著者:: Larisa V. Ivanova, 等
出版事項: (2025-01-01)
Impact of Adherence to Golimumab on Disease Flares in Rheumatoid Arthritis: Results from a Canadian Observational Study
著者:: Bessette L, 等
出版事項: (2025-06-01)
著者:: Bessette L, 等
出版事項: (2025-06-01)
CARDIOVASCULAR DISEASES IN RHEUMATOID ARTHRITIS: LATEST DATA
著者:: T. V. Popkova, 等
出版事項: (2016-07-01)
著者:: T. V. Popkova, 等
出版事項: (2016-07-01)
The clinical and pathogenetic value of Foxp3+ T regulatory cells in rheumatoid arthritis
著者:: A. S. Avdeeva, 等
出版事項: (2016-10-01)
著者:: A. S. Avdeeva, 等
出版事項: (2016-10-01)
Characteristics of patients with difficult-to-treat rheumatoid arthritis: a descriptive retrospective cohort study
著者:: Wen Qi, 等
出版事項: (2024-08-01)
著者:: Wen Qi, 等
出版事項: (2024-08-01)
Recent evidence comparing combination of conventional synthetic disease-modifying antirheumatic drugs with biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
著者:: Abhishek Zanwar, 等
出版事項: (2017-01-01)
著者:: Abhishek Zanwar, 等
出版事項: (2017-01-01)
A discrete choice experiment on preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: the identification, refinement and selection of attributes and levels
著者:: Mathijssen EGE, 等
出版事項: (2018-08-01)
著者:: Mathijssen EGE, 等
出版事項: (2018-08-01)
Effects of IL-6, JAK, TNF inhibitors, and CTLA4-Ig on knee symptoms in patients with rheumatoid arthritis
著者:: Koichi Murata, 等
出版事項: (2024-07-01)
著者:: Koichi Murata, 等
出版事項: (2024-07-01)
Simplified disease activity changes in real-world practice: a nationwide observational study of seropositive rheumatoid arthritis patients with moderate-to-high disease activity
著者:: Kichul Shin, 等
出版事項: (2020-01-01)
著者:: Kichul Shin, 等
出版事項: (2020-01-01)
Body composition and skeletal muscles status in patients with rheumatoid arthritis during treatment with biologic disease-modifying antirheumatic drugs
著者:: O. V. Dobrovolskaya, 等
出版事項: (2025-02-01)
著者:: O. V. Dobrovolskaya, 等
出版事項: (2025-02-01)
類似資料
-
Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials
著者:: Grace C. Wright, 等
出版事項: (2024-07-01) -
Difficult-to-treat rheumatoid arthritis in the clinical practice of a rheumatological hospital. First look
著者:: A. V. Gordeev, 等
出版事項: (2022-05-01) -
Targeted Therapy for Rheumatoid Arthritis in the New Era
著者:: WANG Jun, 等
出版事項: (2025-01-01) -
MODERN VIEWS ON PATHOGENETIC THERAPY OF RHEUMATOID ARTHRITIS
著者:: D. G. Rekalov, 等
出版事項: (2013-12-01) -
Serum IL-40 increases in patients with rheumatoid arthritis and correlates with some clinical characteristics and comorbidities
著者:: Wei Wang, 等
出版事項: (2024-11-01)